Migraine Information Thread, Pharmacokinetic Comparison of 2 Formulations of Anastrozole (1 mg) in Healthy Korean Male Volunteers: A Randomized, Single-Dose, 2-Period, 2-Sequence, Crossover Study. in M; CONCLUSION: The test and reference formulations had similar PK parameters and similar plasma concentration-time profiles. The test formulation of anastrozole ...
-
February 7th, 2012, 8:54 PM
#1
Pharmacokinetic Comparison of 2 Formulations of Anastrozole (1 mg) in Healthy Korean Male Volunteers: A Randomized, Single-Dose, 2-Period, 2-Sequence, Crossover Study.
CONCLUSION: The test and reference formulations had similar PK parameters and similar plasma concentration-time profiles. The test formulation of anastrozole met the Korean regulatory criteria (AUC and C(max)) for assuming bioequivalence. ClinicalTrials.gov identifier: NCT01105299.
PMID: 22281018 [PubMed - as supplied by publisher] (Source: Clinical Therapeutics)
More...
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
LinkBack URL
About LinkBacks
Reply With Quote